1. Full-length 16S rDNA sequencing based on Oxford Nanopore Technologies revealed the association between gut-pharyngeal microbiota and tuberculosis in cynomolgus macaques.
- Author
-
Sawaswong, Vorthon, Chanchaem, Prangwalai, Klomkliew, Pavit, Rotcheewaphan, Suwatchareeporn, Meesawat, Suthirote, Kemthong, Taratorn, Kaewparuehaschai, Mutchamon, Noradechanon, Kirana, Ekatat, Monya, Kanitpun, Reka, Srilohasin, Prapaporn, Warit, Saradee, Chaiprasert, Angkana, Malaivijitnond, Suchinda, and Payungporn, Sunchai
- Subjects
- *
TUBERCULOSIS , *MACAQUES , *MYCOBACTERIUM tuberculosis , *RECOMBINANT DNA , *COMMUNICABLE diseases , *EUBACTERIALES - Abstract
Tuberculosis (TB) is an infectious disease caused by the Mycobacterium tuberculosis complex (Mtbc), which develops from asymptomatic latent TB to active stages. The microbiome was purposed as a potential factor affecting TB pathogenesis, but the study was limited. The present study explored the association between gut-pharyngeal microbiome and TB stages in cynomolgus macaques using the full-length 16S rDNA amplicon sequencing based on Oxford Nanopore Technologies. The total of 71 macaques was divided into TB (−) control, TB (+) latent and TB (+) active groups. The differential abundance analysis showed that Haemophilus hemolyticus was decreased, while Prevotella species were increased in the pharyngeal microbiome of TB (+) macaques. In addition, Eubacterium coprostanoligenes in the gut was enriched in TB (+) macaques. Alteration of these bacteria might affect immune regulation and TB severity, but details of mechanisms should be further explored and validated. In summary, microbiota may be associated with host immune regulation and affect TB progression. The findings suggested the potential mechanisms of host-microbes interaction, which may improve the understanding of the role of microbiota and help develop therapeutics for TB in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF